S. Johansson

First name
S.
Last name
Johansson
Becker, C., Brobert, G. P., Johansson, S., Jick, S. S., & Meier, C. R. (2010). Cancer risk in association with Parkinson disease: a population-based study. Parkinsonism Relat Disord. http://doi.org/10.1016/j.parkreldis.2009.11.005
Becker, C., Brobert, G. P., Johansson, S., Jick, S. S., & Meier, C. R. (2011). Risk of incident depression in patients with Parkinson disease in the UK. Eur J Neurol. http://doi.org/10.1111/j.1468-1331.2010.03176.x
Martin-Merino, E., Johansson, S., Morris, T., & Rodriguez, L. A. G. (2011). Androgen deprivation therapy and the risk of coronary heart disease and heart failure in patients with prostate cancer: a nested case-control study in UK primary care. Drug Saf. http://doi.org/10.2165/11594540-000000000-00000
Rodriguez, L. A. G., Johansson, S., & Soriano, C. (2013). Use of clopidogrel and proton pump inhibitors after a serious acute coronary event: risk of coronary events and peptic ulcer bleeding. Thromb Haemost. http://doi.org/10.1160/th13-03-0225
Rapsomaniki, E., Thuresson, M., Yang, E., Blin, P., Hunt, P., Chung, S. C., et al. (2016). Using big data from health records from four countries to evaluate chronic disease outcomes: a study in 114 364 survivors of myocardial infarction. Eur Heart J Qual Care Clin Outcomes. http://doi.org/10.1093/ehjqcco/qcw004
Huerta, C., Abbing-Karahagopian, V., Requena, G., Oliva, B., Alvarez, Y., Gardarsdottir, H., et al. (2016). Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3825
Requena, G., Huerta, C., Gardarsdottir, H., Logie, J., Gonzalez-Gonzalez, R., Abbing-Karahagopian, V., et al. (2016). Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3816